The weekly litigation news digest is live. Subscribe now

Altor Bioscience competitive analysis

Loading summary...

Explore Altor Bioscience's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 27, 2025
Patent NumberPublication DateTitleTotal Oppositions
Jun 15, 2022Alt-803 In Combination With Anti-Cd38 Antibody For Cancer Therapies1

Latest PTAB cases involving Altor Bioscience

Discover the latest PTAB cases involving Altor Bioscience, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Altor Bioscience with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 27, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALTOR BIOSCIENCE - 1 - -
CYTUNE PHARMA27 - -